

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 7.65782829 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 7.65782829 |
| 3 | * fatty acid elongation (GO:0030497) | 5.46668838 |
| 4 | cholesterol biosynthetic process (GO:0006695) | 4.79328966 |
| 5 | surfactant homeostasis (GO:0043129) | 4.79181383 |
| 6 | axon ensheathment (GO:0008366) | 4.70673372 |
| 7 | ensheathment of neurons (GO:0007272) | 4.70673372 |
| 8 | amyloid precursor protein metabolic process (GO:0042982) | 4.60001271 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.59406178 |
| 10 | myelination (GO:0042552) | 4.59127412 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 4.56980478 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 4.56980478 |
| 13 | adhesion of symbiont to host cell (GO:0044650) | 4.51385434 |
| 14 | virion attachment to host cell (GO:0019062) | 4.51385434 |
| 15 | amyloid precursor protein catabolic process (GO:0042987) | 4.33228956 |
| 16 | sterol biosynthetic process (GO:0016126) | 4.27120971 |
| 17 | myelin maintenance (GO:0043217) | 4.12011168 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.07641380 |
| 19 | barbed-end actin filament capping (GO:0051016) | 4.06496423 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94392607 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90228139 |
| 22 | adhesion of symbiont to host (GO:0044406) | 3.83939927 |
| 23 | desmosome organization (GO:0002934) | 3.74067356 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.70587244 |
| 25 | skin morphogenesis (GO:0043589) | 3.60440608 |
| 26 | isoprenoid biosynthetic process (GO:0008299) | 3.56850038 |
| 27 | membrane raft organization (GO:0031579) | 3.56452802 |
| 28 | sphingosine metabolic process (GO:0006670) | 3.53914134 |
| 29 | response to lipoprotein particle (GO:0055094) | 3.52277485 |
| 30 | hemidesmosome assembly (GO:0031581) | 3.50960619 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46344809 |
| 32 | chemical homeostasis within a tissue (GO:0048875) | 3.42675454 |
| 33 | pinocytosis (GO:0006907) | 3.41066294 |
| 34 | * long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.36826440 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.34564980 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 3.33964131 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.29836837 |
| 38 | * long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.29422173 |
| 39 | creatine metabolic process (GO:0006600) | 3.29198214 |
| 40 | sphingoid metabolic process (GO:0046519) | 3.24422828 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.23126955 |
| 42 | diol metabolic process (GO:0034311) | 3.20133261 |
| 43 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.17565847 |
| 44 | signal peptide processing (GO:0006465) | 3.15874082 |
| 45 | GPI anchor biosynthetic process (GO:0006506) | 3.07510828 |
| 46 | glycosylceramide metabolic process (GO:0006677) | 3.06889704 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.05097446 |
| 48 | autophagic vacuole fusion (GO:0000046) | 2.99503181 |
| 49 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98496199 |
| 50 | * fatty-acyl-CoA metabolic process (GO:0035337) | 2.97316829 |
| 51 | regulation of metalloenzyme activity (GO:0048552) | 2.93808893 |
| 52 | response to methylmercury (GO:0051597) | 2.91667636 |
| 53 | macrophage chemotaxis (GO:0048246) | 2.90104248 |
| 54 | * fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.87834004 |
| 55 | hypotonic response (GO:0006971) | 2.86864274 |
| 56 | oligodendrocyte differentiation (GO:0048709) | 2.82813330 |
| 57 | positive regulation of pseudopodium assembly (GO:0031274) | 2.80077953 |
| 58 | membrane tubulation (GO:0097320) | 2.79829221 |
| 59 | cell adhesion mediated by integrin (GO:0033627) | 2.79344872 |
| 60 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.77953388 |
| 61 | regulation of collateral sprouting (GO:0048670) | 2.77190225 |
| 62 | phagocytosis, engulfment (GO:0006911) | 2.75449983 |
| 63 | low-density lipoprotein particle clearance (GO:0034383) | 2.74781720 |
| 64 | regulation of water loss via skin (GO:0033561) | 2.73221774 |
| 65 | positive regulation of interleukin-17 production (GO:0032740) | 2.70151580 |
| 66 | GPI anchor metabolic process (GO:0006505) | 2.69213335 |
| 67 | positive regulation of actin filament depolymerization (GO:0030836) | 2.68495974 |
| 68 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.67285624 |
| 69 | regulation of lipoprotein metabolic process (GO:0050746) | 2.65525342 |
| 70 | regulation of macrophage chemotaxis (GO:0010758) | 2.65429857 |
| 71 | negative regulation of chemokine production (GO:0032682) | 2.64388174 |
| 72 | membrane protein ectodomain proteolysis (GO:0006509) | 2.63168517 |
| 73 | pentose-phosphate shunt (GO:0006098) | 2.61266666 |
| 74 | nucleotide transmembrane transport (GO:1901679) | 2.60983601 |
| 75 | response to peptidoglycan (GO:0032494) | 2.57181787 |
| 76 | heme transport (GO:0015886) | 2.56822544 |
| 77 | NIK/NF-kappaB signaling (GO:0038061) | 2.56722106 |
| 78 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.55802024 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 2.52266838 |
| 80 | respiratory burst (GO:0045730) | 2.52061620 |
| 81 | regulation of T cell migration (GO:2000404) | 2.51189462 |
| 82 | leukocyte aggregation (GO:0070486) | 2.49771970 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49136286 |
| 84 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.48865539 |
| 85 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.47742283 |
| 86 | * very long-chain fatty acid metabolic process (GO:0000038) | 2.47666703 |
| 87 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.47010165 |
| 88 | hyaluronan catabolic process (GO:0030214) | 2.46996134 |
| 89 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.46695503 |
| 90 | regulation of pseudopodium assembly (GO:0031272) | 2.46581643 |
| 91 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.46253098 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45428538 |
| 93 | negative regulation of protein localization to cell surface (GO:2000009) | 2.45257291 |
| 94 | cell-substrate junction assembly (GO:0007044) | 2.44719980 |
| 95 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.44198080 |
| 96 | negative regulation of acute inflammatory response (GO:0002674) | 2.42728991 |
| 97 | cellular copper ion homeostasis (GO:0006878) | 2.42617789 |
| 98 | establishment of skin barrier (GO:0061436) | 2.41914213 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41873854 |
| 100 | glutathione biosynthetic process (GO:0006750) | 2.41794015 |
| 101 | mesodermal cell differentiation (GO:0048333) | 2.41636296 |
| 102 | fibril organization (GO:0097435) | 2.41265728 |
| 103 | basement membrane organization (GO:0071711) | 2.40789203 |
| 104 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.40655329 |
| 105 | import into cell (GO:0098657) | 2.40525793 |
| 106 | regulation of interleukin-13 production (GO:0032656) | 2.40467497 |
| 107 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.40051641 |
| 108 | mitotic nuclear envelope reassembly (GO:0007084) | 2.38944216 |
| 109 | nuclear envelope reassembly (GO:0031468) | 2.38944216 |
| 110 | cholesterol metabolic process (GO:0008203) | 2.37327223 |
| 111 | detection of bacterium (GO:0016045) | 2.36896309 |
| 112 | response to progesterone (GO:0032570) | 2.36657381 |
| 113 | neutrophil activation (GO:0042119) | 2.35733838 |
| 114 | membrane protein proteolysis (GO:0033619) | 2.35302502 |
| 115 | mannose metabolic process (GO:0006013) | 2.35230939 |
| 116 | detection of other organism (GO:0098543) | 2.34980153 |
| 117 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34738699 |
| 118 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.34538277 |
| 119 | negative regulation of stress fiber assembly (GO:0051497) | 2.34345092 |
| 120 | regulation of extracellular matrix disassembly (GO:0010715) | 2.33903547 |
| 121 | muscle cell migration (GO:0014812) | 2.33537134 |
| 122 | proline biosynthetic process (GO:0006561) | 2.33332350 |
| 123 | response to redox state (GO:0051775) | 2.31046358 |
| 124 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.30807254 |
| 125 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.30094650 |
| 126 | protein localization to endosome (GO:0036010) | 2.29437286 |
| 127 | glycosphingolipid catabolic process (GO:0046479) | 2.29432113 |
| 128 | regulation of superoxide anion generation (GO:0032928) | 2.29051456 |
| 129 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.28910748 |
| 130 | eye photoreceptor cell differentiation (GO:0001754) | 2.28726794 |
| 131 | photoreceptor cell differentiation (GO:0046530) | 2.28726794 |
| 132 | GDP-mannose metabolic process (GO:0019673) | 2.28384327 |
| 133 | apoptotic cell clearance (GO:0043277) | 2.28051395 |
| 134 | substantia nigra development (GO:0021762) | 2.26863362 |
| 135 | stress fiber assembly (GO:0043149) | 2.26854953 |
| 136 | glutathione derivative metabolic process (GO:1901685) | 2.26816953 |
| 137 | glutathione derivative biosynthetic process (GO:1901687) | 2.26816953 |
| 138 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.26703548 |
| 139 | positive regulation of receptor recycling (GO:0001921) | 2.26694871 |
| 140 | response to lead ion (GO:0010288) | 2.26480347 |
| 141 | T-helper 1 type immune response (GO:0042088) | 2.25665059 |
| 142 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25249176 |
| 143 | membrane invagination (GO:0010324) | 2.24894251 |
| 144 | alcohol biosynthetic process (GO:0046165) | 2.24791213 |
| 145 | * acyl-CoA biosynthetic process (GO:0071616) | 2.24124142 |
| 146 | * thioester biosynthetic process (GO:0035384) | 2.24124142 |
| 147 | response to thyroid hormone (GO:0097066) | 2.24109410 |
| 148 | tissue regeneration (GO:0042246) | 2.23940164 |
| 149 | glucose catabolic process (GO:0006007) | 2.23843487 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.23719479 |
| 151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.23511027 |
| 152 | astrocyte development (GO:0014002) | 2.22892650 |
| 153 | histone H4-K12 acetylation (GO:0043983) | 2.22832335 |
| 154 | embryonic process involved in female pregnancy (GO:0060136) | 2.21681177 |
| 155 | mitochondrial calcium ion transport (GO:0006851) | 2.21176767 |
| 156 | NADPH regeneration (GO:0006740) | 2.20617951 |
| 157 | cyclooxygenase pathway (GO:0019371) | 2.20103758 |
| 158 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.19863089 |
| 159 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.19548726 |
| 160 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.19288306 |
| 161 | negative regulation of interleukin-12 production (GO:0032695) | 2.18896335 |
| 162 | myeloid cell homeostasis (GO:0002262) | 2.18718564 |
| 163 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.18644905 |
| 164 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.18499633 |
| 165 | positive regulation of lamellipodium assembly (GO:0010592) | 2.18445446 |
| 166 | positive regulation of protein dephosphorylation (GO:0035307) | 2.17290080 |
| 167 | magnesium ion transport (GO:0015693) | 2.17189982 |
| 168 | regulation of lymphocyte migration (GO:2000401) | 2.16893341 |
| 169 | regulation of necrotic cell death (GO:0010939) | 2.16873461 |
| 170 | mannosylation (GO:0097502) | 2.16601776 |
| 171 | protein palmitoylation (GO:0018345) | 2.16407052 |
| 172 | keratinization (GO:0031424) | 2.16389662 |
| 173 | granulocyte activation (GO:0036230) | 2.16292703 |
| 174 | C-terminal protein lipidation (GO:0006501) | 2.16120632 |
| 175 | glycolipid catabolic process (GO:0019377) | 2.15973166 |
| 176 | aldehyde catabolic process (GO:0046185) | 2.15760585 |
| 177 | lipoxygenase pathway (GO:0019372) | 2.15667197 |
| 178 | cellular defense response (GO:0006968) | 2.14830707 |
| 179 | positive regulation of extracellular matrix organization (GO:1903055) | 2.14372621 |
| 180 | organelle membrane fusion (GO:0090174) | 2.10923668 |
| 181 | regulation of cholesterol storage (GO:0010885) | 2.09621291 |
| 182 | defense response to Gram-negative bacterium (GO:0050829) | 2.08361909 |
| 183 | regulation of defense response to virus by virus (GO:0050690) | 2.08099933 |
| 184 | response to laminar fluid shear stress (GO:0034616) | 2.08005928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.91309749 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.79001353 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73128701 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.64981607 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.63821292 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01560733 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82644249 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.68567582 |
| 9 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.46052301 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.38991573 |
| 11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.27372367 |
| 12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.25385894 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19794919 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17407597 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16674559 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12800324 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07708529 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07622780 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06055862 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05416223 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03728765 |
| 22 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.02780742 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01169801 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00231282 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90327229 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.87504092 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87012190 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86430212 |
| 29 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84211255 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79398751 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74681027 |
| 32 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.74114626 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72290440 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71453030 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61356057 |
| 36 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59161205 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56231784 |
| 38 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.55954627 |
| 39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55010115 |
| 40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.54606974 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53140396 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52824775 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51936623 |
| 44 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50861130 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.50370973 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49723561 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48842998 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48423391 |
| 49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46595139 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44832076 |
| 51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44812474 |
| 52 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44665931 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.44591183 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44388589 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42636289 |
| 56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41849734 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41231635 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40587258 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37758494 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36494749 |
| 61 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.35272115 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34165984 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30075147 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29820635 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29337697 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29022104 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28849953 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27388067 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26117038 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25787237 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25580410 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25526119 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22370906 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21289078 |
| 75 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21245358 |
| 76 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21018833 |
| 77 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.19658870 |
| 78 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.19180634 |
| 79 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18131010 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17925275 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17511760 |
| 82 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16791229 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16306194 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15771931 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15413249 |
| 86 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15004486 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14514600 |
| 88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14263100 |
| 89 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13897472 |
| 90 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12921584 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 1.12644928 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12474598 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12240908 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11683916 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11601959 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10912266 |
| 97 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09625898 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09550722 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.09047833 |
| 100 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08902131 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08720342 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08691226 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 1.08079492 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07543088 |
| 105 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07237668 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06964353 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06653497 |
| 108 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05135914 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04958043 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04958043 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04475500 |
| 112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03487115 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03441892 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02908655 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02738888 |
| 116 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02290902 |
| 117 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02003251 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01951319 |
| 119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01321121 |
| 120 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01271214 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01071513 |
| 122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00782002 |
| 123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99783289 |
| 124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99650984 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99650984 |
| 126 | * MAF_26560356_Chip-Seq_TH1_Human | 0.98807095 |
| 127 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98119559 |
| 128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96992515 |
| 129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96159452 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94696478 |
| 131 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94650133 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94156902 |
| 133 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93884816 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93014574 |
| 135 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.93012546 |
| 136 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.91703274 |
| 137 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91579267 |
| 138 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91490369 |
| 139 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90238634 |
| 140 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89748200 |
| 141 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89655166 |
| 142 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89564238 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89390401 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88717172 |
| 145 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87883441 |
| 146 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86993904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 3.86596105 |
| 2 | MP0004782_abnormal_surfactant_physiolog | 3.43634327 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.41510679 |
| 4 | MP0003724_increased_susceptibility_to | 2.97478941 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.86816042 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.82315452 |
| 7 | MP0001958_emphysema | 2.55400547 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.54618715 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.48512052 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.35120791 |
| 11 | MP0002796_impaired_skin_barrier | 2.30537349 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.23993067 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.21826965 |
| 14 | MP0005451_abnormal_body_composition | 2.20986685 |
| 15 | MP0006082_CNS_inflammation | 2.16731815 |
| 16 | MP0004381_abnormal_hair_follicle | 2.07514026 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.06666316 |
| 18 | MP0009785_altered_susceptibility_to | 2.01419451 |
| 19 | MP0009840_abnormal_foam_cell | 2.01180266 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.00807430 |
| 21 | MP0000383_abnormal_hair_follicle | 1.96943306 |
| 22 | MP0005275_abnormal_skin_tensile | 1.96836829 |
| 23 | MP0010678_abnormal_skin_adnexa | 1.95544050 |
| 24 | MP0003436_decreased_susceptibility_to | 1.93617794 |
| 25 | MP0005083_abnormal_biliary_tract | 1.92540736 |
| 26 | MP0003690_abnormal_glial_cell | 1.90240434 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.88180061 |
| 28 | MP0005025_abnormal_response_to | 1.86077288 |
| 29 | MP0004147_increased_porphyrin_level | 1.83549861 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.81915863 |
| 31 | MP0002419_abnormal_innate_immunity | 1.80891034 |
| 32 | MP0000858_altered_metastatic_potential | 1.80269311 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.78107497 |
| 34 | MP0001851_eye_inflammation | 1.73439335 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.69197499 |
| 36 | MP0004947_skin_inflammation | 1.67602698 |
| 37 | MP0008004_abnormal_stomach_pH | 1.64544266 |
| 38 | MP0002295_abnormal_pulmonary_circulatio | 1.62705689 |
| 39 | MP0005501_abnormal_skin_physiology | 1.61053468 |
| 40 | MP0005387_immune_system_phenotype | 1.60916981 |
| 41 | MP0001790_abnormal_immune_system | 1.60916981 |
| 42 | MP0000685_abnormal_immune_system | 1.57057548 |
| 43 | MP0003279_aneurysm | 1.51198379 |
| 44 | MP0003186_abnormal_redox_activity | 1.50589399 |
| 45 | MP0006054_spinal_hemorrhage | 1.48756250 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.48498049 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.45175732 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.37806150 |
| 49 | MP0002933_joint_inflammation | 1.37346080 |
| 50 | MP0001849_ear_inflammation | 1.37138346 |
| 51 | MP0005408_hypopigmentation | 1.36675876 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.36132716 |
| 53 | MP0002723_abnormal_immune_serum | 1.35237590 |
| 54 | MP0005166_decreased_susceptibility_to | 1.34849894 |
| 55 | MP0005671_abnormal_response_to | 1.32346781 |
| 56 | MP0003091_abnormal_cell_migration | 1.31250096 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.27105438 |
| 58 | MP0003136_yellow_coat_color | 1.25535099 |
| 59 | MP0008260_abnormal_autophagy | 1.25447538 |
| 60 | MP0002405_respiratory_system_inflammati | 1.22123156 |
| 61 | MP0003329_amyloid_beta_deposits | 1.22105971 |
| 62 | MP0002133_abnormal_respiratory_system | 1.21204686 |
| 63 | MP0005388_respiratory_system_phenotype | 1.21204686 |
| 64 | MP0000604_amyloidosis | 1.20630190 |
| 65 | MP0002098_abnormal_vibrissa_morphology | 1.20060577 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.18074174 |
| 67 | MP0002060_abnormal_skin_morphology | 1.17313969 |
| 68 | MP0001853_heart_inflammation | 1.17158692 |
| 69 | MP0002132_abnormal_respiratory_system | 1.16929275 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.16744646 |
| 71 | MP0000343_altered_response_to | 1.16540305 |
| 72 | MP0001819_abnormal_immune_cell | 1.15757886 |
| 73 | MP0001216_abnormal_epidermal_layer | 1.14746597 |
| 74 | MP0005165_increased_susceptibility_to | 1.12757086 |
| 75 | MP0001243_abnormal_dermal_layer | 1.11910947 |
| 76 | MP0000647_abnormal_sebaceous_gland | 1.10908351 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.08856408 |
| 78 | MP0003075_altered_response_to | 1.07901424 |
| 79 | MP0001800_abnormal_humoral_immune | 1.06991619 |
| 80 | MP0005164_abnormal_response_to | 1.06395670 |
| 81 | MP0010771_integument_phenotype | 1.06352131 |
| 82 | MP0003303_peritoneal_inflammation | 1.05899123 |
| 83 | MP0003634_abnormal_glial_cell | 1.04944540 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.04502061 |
| 85 | MP0004883_abnormal_blood_vessel | 1.03970211 |
| 86 | MP0004858_abnormal_nervous_system | 1.03963393 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.03926907 |
| 88 | MP0001915_intracranial_hemorrhage | 1.02842179 |
| 89 | MP0000750_abnormal_muscle_regeneration | 1.02821716 |
| 90 | MP0004272_abnormal_basement_membrane | 1.00742722 |
| 91 | MP0001542_abnormal_bone_strength | 0.99856622 |
| 92 | MP0008469_abnormal_protein_level | 0.99732510 |
| 93 | MP0005023_abnormal_wound_healing | 0.98300344 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.97863621 |
| 95 | MP0000377_abnormal_hair_follicle | 0.96473628 |
| 96 | MP0005623_abnormal_meninges_morphology | 0.95604249 |
| 97 | MP0000566_synostosis | 0.94382749 |
| 98 | MP0005409_darkened_coat_color | 0.93966423 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.92501100 |
| 100 | MP0000579_abnormal_nail_morphology | 0.92333299 |
| 101 | MP0010352_gastrointestinal_tract_polyps | 0.91455559 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.90946421 |
| 103 | MP0003828_pulmonary_edema | 0.89063614 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.88894994 |
| 105 | MP0003045_fibrosis | 0.86994841 |
| 106 | MP0005390_skeleton_phenotype | 0.86716798 |
| 107 | MP0003448_altered_tumor_morphology | 0.86377910 |
| 108 | MP0003195_calcinosis | 0.85996276 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.85767222 |
| 110 | MP0004742_abnormal_vestibular_system | 0.84400677 |
| 111 | MP0000249_abnormal_blood_vessel | 0.83412123 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.82910756 |
| 113 | MP0009764_decreased_sensitivity_to | 0.82112206 |
| 114 | MP0003795_abnormal_bone_structure | 0.81659628 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.81370351 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.80165938 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.79995433 |
| 118 | MP0000462_abnormal_digestive_system | 0.79918508 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.79908259 |
| 120 | MP0003011_delayed_dark_adaptation | 0.79600761 |
| 121 | MP0000716_abnormal_immune_system | 0.79397242 |
| 122 | MP0004510_myositis | 0.78798442 |
| 123 | MP0001177_atelectasis | 0.77638463 |
| 124 | MP0005360_urolithiasis | 0.76415790 |
| 125 | MP0002896_abnormal_bone_mineralization | 0.76349951 |
| 126 | MP0005171_absent_coat_pigmentation | 0.75659094 |
| 127 | MP0009931_abnormal_skin_appearance | 0.75461101 |
| 128 | MP0001346_abnormal_lacrimal_gland | 0.74808997 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.74736401 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.72119857 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.71854990 |
| 132 | MP0003632_abnormal_nervous_system | 0.70073029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 5.37496774 |
| 2 | Interstitial pulmonary disease (HP:0006530) | 4.95088451 |
| 3 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.85256689 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.54437388 |
| 5 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.45961294 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.89945947 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.57828359 |
| 8 | Axonal loss (HP:0003447) | 3.45849693 |
| 9 | Hepatosplenomegaly (HP:0001433) | 3.43208176 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.38536226 |
| 11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.16932031 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.16932031 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.16448573 |
| 14 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.16324535 |
| 15 | Achilles tendon contracture (HP:0001771) | 3.11891578 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.08061277 |
| 17 | Loss of speech (HP:0002371) | 3.02348860 |
| 18 | Chronic otitis media (HP:0000389) | 3.02146479 |
| 19 | Recurrent abscess formation (HP:0002722) | 2.97892818 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.93697270 |
| 21 | Peripheral hypomyelination (HP:0007182) | 2.92437532 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.91370184 |
| 23 | Sensory axonal neuropathy (HP:0003390) | 2.89722797 |
| 24 | Premature skin wrinkling (HP:0100678) | 2.89344871 |
| 25 | Stridor (HP:0010307) | 2.84946608 |
| 26 | Cerebral hypomyelination (HP:0006808) | 2.82364934 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 2.82143483 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.82004927 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 2.78449065 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78074126 |
| 31 | Onion bulb formation (HP:0003383) | 2.65132314 |
| 32 | Erythroderma (HP:0001019) | 2.54275110 |
| 33 | Atrophic scars (HP:0001075) | 2.52415358 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.51111251 |
| 35 | Respiratory distress (HP:0002098) | 2.47843065 |
| 36 | Prolonged neonatal jaundice (HP:0006579) | 2.47240471 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.46059718 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.46059718 |
| 39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45848202 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 2.45848202 |
| 41 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.45658382 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.45655550 |
| 43 | Abnormality of nail color (HP:0100643) | 2.42399648 |
| 44 | Recurrent skin infections (HP:0001581) | 2.36406847 |
| 45 | Fragile skin (HP:0001030) | 2.35975152 |
| 46 | Short nail (HP:0001799) | 2.31257153 |
| 47 | Cerebral hemorrhage (HP:0001342) | 2.29642857 |
| 48 | Purpura (HP:0000979) | 2.28039609 |
| 49 | Cervical subluxation (HP:0003308) | 2.27659654 |
| 50 | Increased connective tissue (HP:0009025) | 2.24059789 |
| 51 | Premature rupture of membranes (HP:0001788) | 2.23621613 |
| 52 | Stomatitis (HP:0010280) | 2.21915961 |
| 53 | Hypertriglyceridemia (HP:0002155) | 2.21274407 |
| 54 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.20393508 |
| 55 | Autoamputation (HP:0001218) | 2.18753302 |
| 56 | Renal salt wasting (HP:0000127) | 2.16701382 |
| 57 | Petechiae (HP:0000967) | 2.15737557 |
| 58 | Plantar hyperkeratosis (HP:0007556) | 2.12237453 |
| 59 | Renal Fanconi syndrome (HP:0001994) | 2.11304883 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11296869 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11296869 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11296869 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 2.11072899 |
| 64 | Spastic paraparesis (HP:0002313) | 2.09934718 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09229691 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.09229691 |
| 67 | Thick nail (HP:0001805) | 2.08806464 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.06110434 |
| 69 | Patchy hypopigmentation of hair (HP:0011365) | 2.02744769 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.01314269 |
| 71 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.01301402 |
| 72 | Single umbilical artery (HP:0001195) | 2.01301402 |
| 73 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.01301402 |
| 74 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01019556 |
| 75 | Alopecia of scalp (HP:0002293) | 2.00511743 |
| 76 | Ileus (HP:0002595) | 2.00487615 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.00402489 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.00402489 |
| 79 | Erythema (HP:0010783) | 2.00208387 |
| 80 | Ectropion (HP:0000656) | 1.99995894 |
| 81 | Nail dystrophy (HP:0008404) | 1.99130277 |
| 82 | Amyloidosis (HP:0011034) | 1.97365260 |
| 83 | Gangrene (HP:0100758) | 1.96631481 |
| 84 | Acanthosis nigricans (HP:0000956) | 1.95763165 |
| 85 | White forelock (HP:0002211) | 1.95162229 |
| 86 | Abnormality of the umbilical cord (HP:0010881) | 1.93633325 |
| 87 | Abnormal blistering of the skin (HP:0008066) | 1.92698844 |
| 88 | Xanthomatosis (HP:0000991) | 1.92085671 |
| 89 | Hypoplastic pelvis (HP:0008839) | 1.91305328 |
| 90 | Myocardial infarction (HP:0001658) | 1.91059260 |
| 91 | Dysostosis multiplex (HP:0000943) | 1.90285503 |
| 92 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.90064144 |
| 93 | Glucose intolerance (HP:0000833) | 1.88930969 |
| 94 | Elbow flexion contracture (HP:0002987) | 1.88863608 |
| 95 | Peripheral demyelination (HP:0011096) | 1.88074652 |
| 96 | Slow saccadic eye movements (HP:0000514) | 1.87962536 |
| 97 | Abnormal auditory evoked potentials (HP:0006958) | 1.87938958 |
| 98 | Peritonitis (HP:0002586) | 1.87750629 |
| 99 | Trismus (HP:0000211) | 1.87740422 |
| 100 | Pustule (HP:0200039) | 1.86392334 |
| 101 | Nonimmune hydrops fetalis (HP:0001790) | 1.85658932 |
| 102 | Joint stiffness (HP:0001387) | 1.85597802 |
| 103 | Corneal erosion (HP:0200020) | 1.83114532 |
| 104 | Polygenic inheritance (HP:0010982) | 1.82788895 |
| 105 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82594165 |
| 106 | Hypokalemic alkalosis (HP:0001949) | 1.82494836 |
| 107 | Wormian bones (HP:0002645) | 1.81434242 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 1.80803804 |
| 109 | Increased serum ferritin (HP:0003281) | 1.80619711 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.79824692 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 1.79443412 |
| 112 | Rough bone trabeculation (HP:0100670) | 1.79222726 |
| 113 | Partial duplication of thumb phalanx (HP:0009944) | 1.78411738 |
| 114 | Paralysis (HP:0003470) | 1.78182140 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 1.77602134 |
| 116 | Hypertensive crisis (HP:0100735) | 1.77269549 |
| 117 | Bone pain (HP:0002653) | 1.76771076 |
| 118 | Hypomagnesemia (HP:0002917) | 1.76758763 |
| 119 | Dilatation of the ascending aorta (HP:0005111) | 1.76699157 |
| 120 | Increased IgE level (HP:0003212) | 1.76614138 |
| 121 | Spinal rigidity (HP:0003306) | 1.76476344 |
| 122 | Cholecystitis (HP:0001082) | 1.76024143 |
| 123 | Abnormal gallbladder physiology (HP:0012438) | 1.76024143 |
| 124 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75248963 |
| 125 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75248963 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75248963 |
| 127 | Palmar hyperkeratosis (HP:0010765) | 1.74226042 |
| 128 | Thin bony cortex (HP:0002753) | 1.74159076 |
| 129 | Leukodystrophy (HP:0002415) | 1.74111485 |
| 130 | Onycholysis (HP:0001806) | 1.73906421 |
| 131 | Generalized amyotrophy (HP:0003700) | 1.72489459 |
| 132 | Spinal cord lesions (HP:0100561) | 1.72135905 |
| 133 | Syringomyelia (HP:0003396) | 1.72135905 |
| 134 | Pili torti (HP:0003777) | 1.71945885 |
| 135 | Abnormal hair laboratory examination (HP:0003328) | 1.71318423 |
| 136 | Follicular hyperkeratosis (HP:0007502) | 1.70705860 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70350657 |
| 138 | Natal tooth (HP:0000695) | 1.70018607 |
| 139 | Blue sclerae (HP:0000592) | 1.69068561 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.68366286 |
| 141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67426337 |
| 142 | J-shaped sella turcica (HP:0002680) | 1.67205843 |
| 143 | Pruritus (HP:0000989) | 1.66864980 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.66724481 |
| 145 | Ulnar bowing (HP:0003031) | 1.66585616 |
| 146 | Tubulointerstitial fibrosis (HP:0005576) | 1.65810850 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.65687558 |
| 148 | Nuclear cataract (HP:0100018) | 1.65651632 |
| 149 | Cerebral aneurysm (HP:0004944) | 1.65605967 |
| 150 | Episodic fever (HP:0001954) | 1.65490543 |
| 151 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64875050 |
| 152 | Ankle contracture (HP:0006466) | 1.64256919 |
| 153 | Cellulitis (HP:0100658) | 1.63966545 |
| 154 | 3-Methylglutaconic aciduria (HP:0003535) | 1.63687611 |
| 155 | Cardiovascular calcification (HP:0011915) | 1.63389256 |
| 156 | Entropion (HP:0000621) | 1.62856978 |
| 157 | Urticaria (HP:0001025) | 1.62803074 |
| 158 | Stenosis of the external auditory canal (HP:0000402) | 1.61513408 |
| 159 | Seborrheic dermatitis (HP:0001051) | 1.57884843 |
| 160 | Anhidrosis (HP:0000970) | 1.56664247 |
| 161 | Barrel-shaped chest (HP:0001552) | 1.56432442 |
| 162 | Gingival bleeding (HP:0000225) | 1.55426054 |
| 163 | Chronic obstructive pulmonary disease (HP:0006510) | 1.55226483 |
| 164 | Obstructive lung disease (HP:0006536) | 1.55226483 |
| 165 | Abnormality of the 2nd finger (HP:0004100) | 1.54702931 |
| 166 | Fragile nails (HP:0001808) | 1.54525502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.83829710 |
| 2 | EPHB1 | 4.54847236 |
| 3 | TESK2 | 3.28192000 |
| 4 | MST4 | 3.07407273 |
| 5 | EPHA2 | 3.05156981 |
| 6 | PBK | 3.03965704 |
| 7 | OXSR1 | 3.03561131 |
| 8 | MAPKAPK5 | 2.48009038 |
| 9 | TRIB3 | 2.38454389 |
| 10 | LIMK1 | 2.21516848 |
| 11 | MET | 2.14275854 |
| 12 | BLK | 2.05520361 |
| 13 | WNK4 | 1.98422150 |
| 14 | RIPK1 | 1.95094697 |
| 15 | PTK2 | 1.94950676 |
| 16 | PIM2 | 1.88780265 |
| 17 | AKT3 | 1.88030110 |
| 18 | SCYL2 | 1.85158268 |
| 19 | SMG1 | 1.79690356 |
| 20 | NME2 | 1.75811963 |
| 21 | PKN1 | 1.70055504 |
| 22 | CDK19 | 1.63828891 |
| 23 | BCR | 1.59825560 |
| 24 | MAP4K1 | 1.59143705 |
| 25 | SIK1 | 1.55094729 |
| 26 | CLK1 | 1.54733803 |
| 27 | LRRK2 | 1.54632788 |
| 28 | TAOK2 | 1.52174875 |
| 29 | TRPM7 | 1.52157517 |
| 30 | FGFR2 | 1.46934386 |
| 31 | STK10 | 1.43664781 |
| 32 | TIE1 | 1.41074793 |
| 33 | BRAF | 1.39755152 |
| 34 | KDR | 1.39540814 |
| 35 | TAF1 | 1.38505785 |
| 36 | ZAP70 | 1.37402733 |
| 37 | ERN1 | 1.33344420 |
| 38 | TBK1 | 1.30079531 |
| 39 | LMTK2 | 1.29899912 |
| 40 | IRAK4 | 1.29600314 |
| 41 | MAPKAPK3 | 1.25803319 |
| 42 | TESK1 | 1.25068697 |
| 43 | MAP3K14 | 1.19640447 |
| 44 | TGFBR2 | 1.17351813 |
| 45 | KIT | 1.11275657 |
| 46 | BMPR1B | 1.08460287 |
| 47 | CSNK1G3 | 1.07860347 |
| 48 | MST1R | 1.06284771 |
| 49 | IKBKE | 1.05069827 |
| 50 | CSK | 1.04390053 |
| 51 | PRKD2 | 1.02672624 |
| 52 | ICK | 1.02022487 |
| 53 | CSNK1A1L | 0.99334705 |
| 54 | ROCK2 | 0.93812484 |
| 55 | MOS | 0.93608240 |
| 56 | PDGFRA | 0.93140272 |
| 57 | IKBKB | 0.92419103 |
| 58 | ILK | 0.89355890 |
| 59 | BTK | 0.88773330 |
| 60 | TYK2 | 0.88761558 |
| 61 | TEC | 0.87778442 |
| 62 | TNIK | 0.87156272 |
| 63 | DAPK1 | 0.86866140 |
| 64 | ITK | 0.86231850 |
| 65 | TTN | 0.86013826 |
| 66 | FGR | 0.85925948 |
| 67 | PRKCQ | 0.84988201 |
| 68 | MAP3K1 | 0.84245039 |
| 69 | RIPK4 | 0.82373492 |
| 70 | ABL2 | 0.80358498 |
| 71 | MAP2K2 | 0.80200500 |
| 72 | PTK6 | 0.76280764 |
| 73 | MAP3K3 | 0.74983460 |
| 74 | CSNK1G1 | 0.74859791 |
| 75 | MAP3K8 | 0.74337096 |
| 76 | PRPF4B | 0.71488045 |
| 77 | WNK1 | 0.71359918 |
| 78 | RPS6KA5 | 0.70617273 |
| 79 | NEK6 | 0.70223486 |
| 80 | LCK | 0.70186627 |
| 81 | PIK3CG | 0.69396081 |
| 82 | BCKDK | 0.68841105 |
| 83 | MAPK15 | 0.68403724 |
| 84 | CSF1R | 0.67649237 |
| 85 | JAK3 | 0.67534202 |
| 86 | PRKD1 | 0.67313933 |
| 87 | TXK | 0.67036126 |
| 88 | HIPK2 | 0.65828959 |
| 89 | MAP3K6 | 0.63397261 |
| 90 | MARK3 | 0.61817530 |
| 91 | PRKG2 | 0.61673992 |
| 92 | TAOK1 | 0.61043494 |
| 93 | KSR1 | 0.61022567 |
| 94 | DDR2 | 0.60389056 |
| 95 | EIF2AK3 | 0.60303758 |
| 96 | GSK3A | 0.59988291 |
| 97 | IRAK3 | 0.59473739 |
| 98 | MAP3K12 | 0.58836145 |
| 99 | MAP3K13 | 0.56789620 |
| 100 | PAK1 | 0.56454368 |
| 101 | PRKCI | 0.56426624 |
| 102 | LYN | 0.56323562 |
| 103 | MAP3K11 | 0.56275618 |
| 104 | MAPKAPK2 | 0.54446431 |
| 105 | STK4 | 0.54139394 |
| 106 | VRK2 | 0.53909387 |
| 107 | TAOK3 | 0.53881439 |
| 108 | EPHB2 | 0.53252958 |
| 109 | PDGFRB | 0.52966123 |
| 110 | JAK1 | 0.51960303 |
| 111 | NEK9 | 0.51790388 |
| 112 | ABL1 | 0.51462791 |
| 113 | TLK1 | 0.51445196 |
| 114 | PAK4 | 0.50874601 |
| 115 | BMX | 0.50684772 |
| 116 | EIF2AK1 | 0.49799545 |
| 117 | CDC42BPA | 0.49660852 |
| 118 | CAMK2B | 0.49380255 |
| 119 | STK16 | 0.49270075 |
| 120 | BUB1 | 0.47229075 |
| 121 | PAK2 | 0.46885689 |
| 122 | PDPK1 | 0.46563050 |
| 123 | PRKCD | 0.45937654 |
| 124 | STK24 | 0.45606219 |
| 125 | KSR2 | 0.45185473 |
| 126 | GRK1 | 0.44899442 |
| 127 | DAPK3 | 0.44672218 |
| 128 | FYN | 0.43671874 |
| 129 | GRK6 | 0.42915953 |
| 130 | PKN2 | 0.42828401 |
| 131 | SYK | 0.42598751 |
| 132 | CAMK2D | 0.41567892 |
| 133 | MAP2K3 | 0.41504013 |
| 134 | MYLK | 0.41366640 |
| 135 | CAMK2G | 0.40505527 |
| 136 | ARAF | 0.39853944 |
| 137 | MAPK11 | 0.39779423 |
| 138 | NLK | 0.39779263 |
| 139 | FGFR4 | 0.37997508 |
| 140 | CSNK1G2 | 0.37929405 |
| 141 | HCK | 0.37137907 |
| 142 | PDK2 | 0.36356152 |
| 143 | SIK3 | 0.36264050 |
| 144 | ERBB4 | 0.36048858 |
| 145 | MAP2K6 | 0.35882915 |
| 146 | NTRK1 | 0.34990491 |
| 147 | UHMK1 | 0.34952425 |
| 148 | MAP2K1 | 0.33543324 |
| 149 | MAP3K2 | 0.33137982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.64009835 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.51207159 |
| 3 | * Fatty acid elongation_Homo sapiens_hsa00062 | 3.34574416 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.62428853 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.58866087 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.52143056 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.31069575 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.26067795 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17226642 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13868530 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.93789076 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91490355 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.88403859 |
| 14 | Bladder cancer_Homo sapiens_hsa05219 | 1.80206750 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.78776592 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77677731 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.60458330 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.56958474 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46375829 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45844254 |
| 21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42694850 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.41614259 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.35616344 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.35064812 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33600740 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.33126823 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.32317466 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.31720767 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.31589566 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31193318 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29186951 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.26474546 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25829801 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24839023 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24659305 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.24610992 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23035624 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22589849 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21756370 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21528956 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21274617 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21086409 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20208599 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19893979 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.19886428 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19853084 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17735711 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16167305 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15916561 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15895456 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12411156 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10428861 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09715203 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05785558 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.05744055 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05472416 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 1.03745686 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01136501 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.00304205 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00230296 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99060974 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.95984467 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95530779 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95417094 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95310925 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.92184616 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90480330 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90232125 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89836678 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88810635 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88101154 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87788186 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.87669096 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.87463121 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.85372456 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84213987 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83153758 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82532483 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81829448 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81827653 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79158272 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78863440 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78284691 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77450663 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76105364 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75964371 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.75957690 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74196362 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73710686 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71571255 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70678521 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69995811 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69895375 |
| 94 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69029155 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68215729 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68011274 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67645151 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66579395 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65981995 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63276004 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.62280774 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62051703 |
| 103 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61949098 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.61854433 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60914554 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60274028 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58852603 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58573182 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57770185 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.56621084 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56478147 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.54563539 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54556725 |
| 114 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54456238 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53477231 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53369414 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52307978 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.51924853 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.51363576 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.51361828 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51315459 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50827691 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50663001 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50502071 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49878171 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49605360 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49275144 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48671370 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48203907 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46731258 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46539277 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46213767 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45206309 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43540811 |
| 135 | Measles_Homo sapiens_hsa05162 | 0.42873685 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42857533 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42410125 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41662703 |
| 139 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41174647 |
| 140 | Apoptosis_Homo sapiens_hsa04210 | 0.40846081 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.39374445 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39002710 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37705230 |
| 144 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37647400 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36187809 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.35731765 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35055338 |

